2023
Characteristics and Treatments of Coronavirus Disease 2019 Patients Presenting With Persistent Hiccups: A Scoping Review
Boulis M, Boulis M, Cosgrove M, He K. Characteristics and Treatments of Coronavirus Disease 2019 Patients Presenting With Persistent Hiccups: A Scoping Review. Clinical Neuropharmacology 2023, 46: 157-163. PMID: 37212668, DOI: 10.1097/wnf.0000000000000554.Peer-Reviewed Original ResearchPersistent hiccupsCOVID-19 patientsChest imagingCharacteristics of COVID-19 patientsReverse transcriptase-polymerase chain reactionTranscriptase-polymerase chain reactionManifestations of COVID-19Reverse transcriptase-polymerase chain reaction testSymptoms of infectionAtypical presentationLung involvementFavorable outcomeTreatment optionsDifferential diagnosisTreatment of coronavirus diseasePatientsCoronavirus disease 2019HiccupsChain reactionMetoclopramideReaction testCOVID-19Scoping ReviewTreatmentChlorpromazine
2022
Antipsychotic-Related Risks of Type 2 Diabetes Mellitus in Enrollees With Schizophrenia in the National Basic Public Health Service Program in Hunan Province, China
Ouyang F, He J, Cheng X, Zhou W, Xiao S, Fang J. Antipsychotic-Related Risks of Type 2 Diabetes Mellitus in Enrollees With Schizophrenia in the National Basic Public Health Service Program in Hunan Province, China. Frontiers In Psychiatry 2022, 13: 754775. PMID: 35280179, PMCID: PMC8909132, DOI: 10.3389/fpsyt.2022.754775.Peer-Reviewed Original ResearchAntipsychotic usePatients’ baseline body mass index.Public Health Service ProgramType 2 diabetes mellitusMental health officersAntipsychotic monotherapyRisk of T2DMSchizophreniaAntipsychoticsProportion of animal productsCumulative person-yearsBaseline fasting plasma glucose levelsHazard ratioClozapineRisperidoneRisk of type 2 diabetes mellitusFasting plasma glucose levelsT2DM riskBaseline body mass indexDiabetes-free patientsPerphenazineHealth service programsDevelopment of type 2 diabetes mellitusChlorpromazineHigher risk of T2DM
2001
Chlorpromazine Alters Outer Hair Cell Electromotility
Lue A, Zhao H, Brownell W. Chlorpromazine Alters Outer Hair Cell Electromotility. Otolaryngology 2001, 125: 71-76. PMID: 11458218, DOI: 10.1067/mhn.2001.116446.Peer-Reviewed Original ResearchConceptsOuter hair cellsHair cellsDose-dependent depolarizationGuinea pig outer hair cellsEffect of chlorpromazineElectromotile responseAntipsychotic medicationChlorpromazine treatmentHearing thresholdsLarge dosesCochlear sensitivityOtoacoustic emissionsInner earChlorpromazineOuter hair cell electromotilityHair cell electromotilityOHC electromotilityMembrane voltageRecording conditionsCellsMedicationsResponseElectromotility
1982
Effect of Chlorpromazine on Hepatic Clearance and Excretion of Bile Acids by the Isolated Perfused Rat Liver 1
Tavoloni N, Reed J, Boyer J. Effect of Chlorpromazine on Hepatic Clearance and Excretion of Bile Acids by the Isolated Perfused Rat Liver 1. Experimental Biology And Medicine 1982, 170: 486-492. PMID: 7122478, DOI: 10.3181/00379727-170-41463.Peer-Reviewed Original ResearchConceptsBile acid excretionAcid excretionEffect of chlorpromazineBile acidsRat liverRat liver 1Glutamic oxalacetic transaminase activityHepatic perfusionHepatic functionTransaminase releasePerfusate concentrationPerfusate flowConstant infusionDrug AdministrationBile acid extractionControl liversHepatic clearanceGlutamic pyruvicTransaminase activityExcretionSodium taurocholateLiver 1Eventual excretionLiverChlorpromazine
1974
A comparison of the effects of chlorpromazine, 7-hydroxychlorpromazine and chlorpromazine sulfoxide on the activity of central dopaminergic neurons
Bunney B, Aghajanian G. A comparison of the effects of chlorpromazine, 7-hydroxychlorpromazine and chlorpromazine sulfoxide on the activity of central dopaminergic neurons. Life Sciences 1974, 15: 309-318. PMID: 4549921, DOI: 10.1016/0024-3205(74)90221-5.Peer-Reviewed Original ResearchConceptsChlorpromazine sulfoxideSingle-unit recording techniquesAnti-psychotic propertyCentral dopaminergic neuronsVentral tegmental neuronsPossible clinical importanceEffect of chlorpromazineA10 neuronsDopaminergic neuronsAntipsychotic efficacyPlasma levelsTegmental neuronsAntipsychotic agentsTherapeutic effectAntipsychotic propertiesClinical importanceEquivalent dosesRecording techniquesChlorpromazineNeuronsDepressionPreliminary studyPrevious findingsSulfoxide levelsChlorpromazine metabolites
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply